Skip to main content

Stereotaxis, Inc.

STXS
Exchange
NYSE
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001289340

No open-market purchases or sales by Stereotaxis, Inc. insiders were filed in the last 90 days; 108 institutions reported holding it in 13F filings for Q2 2026, worth $74.1M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Stereotaxis, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of STXS: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders8173−8
Shares40.5M40.2M−277.9K (−0.7%)
Value$105.7M$73.2M−$32.5M (−30.8%)

New holders (18)

Institutions that held Stereotaxis, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to STXS in Q2 2024
InstitutionSharesValue% of portfolio
GMT Capital Corp126,581$230.4K0.01%
Nuveen Asset Management, LLC73,990$134.7K0.00%
New York State Common Retirement Fund56,900$103.6K0.00%
Alpine Global Management, LLC52,052$94.7K0.02%
Envestnet Asset Management Inc47,128$85.8K0.00%
Corebridge Financial, Inc.29,490$54.0K0.00%
Forum Financial Management, LP26,518$48.3K0.00%
Invesco Ltd.26,327$47.9K0.00%
Robinswood Financial LLC19,000$34.6K0.01%
Barclays PLC18,541$33.7K0.00%
Quadrature Capital Ltd13,744$24.4K0.00%
Raymond James & Associates10,350$18.8K0.00%
Legal & General Group Plc5,955$10.6K0.00%
Ameritas Investment Partners, Inc.5,370$9.77K0.00%
California State Teachers Retirement System3,972$7.23K0.00%
Amalgamated Bank1,897$3.00K0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC50$910.00%
Innealta Capital, LLC23$420.00%

Sold out (26)

Institutions that held Stereotaxis, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.